Optimizing Outcomes in Patients With RCC: Translating Evidence to Clinical Practice
Expert panelists from the UT Southwestern Medical Center review real world patient cases of renal cell carcinoma to illustrate recent clinical data and exhibit how it has been applied at their institution.
EP. 1: Scenario 1: A 47-Year-Old Man With Intermediate Risk Metastatic RCC
Expert perspectives on a patient scenario of intermediate risk metastatic renal cell carcinoma and corresponding management with combination immunotherapy.
EP. 2: Role of Combination Immunotherapy in Metastatic Renal Cell Carcinoma
Key opinion leaders in the field of renal cell carcinoma management discuss the advent of combination immunotherapy in patients with metastatic disease.
EP. 3: Scenario 2: A 59-Year-Old Man With Favorable Risk Metastatic RCC
Moving on to the second patient scenario of renal cell carcinoma, panelists reflect on the treatment pathway for favorable risk metastatic disease.
EP. 4: Combination IO TKI Therapy in Patients With Metastatic Renal Cell Carcinoma
Focused discussion on combination IO-TKI therapy and its role as first-line therapy in patients diagnosed with metastatic renal cell carcinoma.
EP. 5: Scenario 3: A 44-Year-Old Woman With RCC at Intermediate-High Risk for Recurrence
Expert panelists highlight aspects of a final patient scenario, discussing adjuvant treatment strategies in the setting of renal cell carcinoma at intermediate-high risk for recurrence.
EP. 6: Multidisciplinary Strategies in RCC Management: Future Directions in Care
Closing out their discussion on renal cell carcinoma, key opinion leaders highlight the value of multidisciplinary care and look toward future evolutions in the treatment paradigm.
